Clinical Trial Update: Neoadjuvant Treatment in Resectable Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 neoadjuvant trial for resectable pancreatic cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Pancreatic Cancer | Phase 3 | Status: TERMINATED